CL2008000322A1 - Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios. - Google Patents
Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios.Info
- Publication number
- CL2008000322A1 CL2008000322A1 CL200800322A CL2008000322A CL2008000322A1 CL 2008000322 A1 CL2008000322 A1 CL 2008000322A1 CL 200800322 A CL200800322 A CL 200800322A CL 2008000322 A CL2008000322 A CL 2008000322A CL 2008000322 A1 CL2008000322 A1 CL 2008000322A1
- Authority
- CL
- Chile
- Prior art keywords
- preparation
- compounds
- quinolina
- tiazol
- compound derived
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 3
- 238000002360 preparation method Methods 0.000 title 2
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07101571 | 2007-02-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2008000322A1 true CL2008000322A1 (es) | 2008-09-05 |
Family
ID=38337997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200800322A CL2008000322A1 (es) | 2007-02-01 | 2008-02-01 | Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios. |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US8212043B2 (es) |
| EP (1) | EP2121674B1 (es) |
| JP (1) | JP5563830B2 (es) |
| KR (1) | KR101598135B1 (es) |
| CN (3) | CN101600713B (es) |
| AR (1) | AR065137A1 (es) |
| AT (1) | ATE467630T1 (es) |
| AU (1) | AU2008209697B2 (es) |
| BR (1) | BRPI0806853B1 (es) |
| CA (1) | CA2677173C (es) |
| CL (1) | CL2008000322A1 (es) |
| CY (1) | CY1110893T1 (es) |
| DE (1) | DE602008001251D1 (es) |
| DK (1) | DK2121674T3 (es) |
| ES (1) | ES2345857T3 (es) |
| HK (1) | HK1217952A1 (es) |
| HR (1) | HRP20100429T1 (es) |
| IL (1) | IL199276A (es) |
| MX (1) | MX2009008271A (es) |
| PL (1) | PL2121674T3 (es) |
| PT (1) | PT2121674E (es) |
| RU (1) | RU2483067C2 (es) |
| SI (1) | SI2121674T1 (es) |
| TW (1) | TWI455936B (es) |
| WO (1) | WO2008092955A1 (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| HRP20100429T1 (hr) * | 2007-02-01 | 2010-09-30 | Tibotec Pharmaceuticals | Postupci i intermedijeri za pripravu makrocikličkog inhibitora proteaze za hcv |
| US8207341B2 (en) | 2008-09-04 | 2012-06-26 | Bristol-Myers Squibb Company | Process or synthesizing substituted isoquinolines |
| BRPI0923393B1 (pt) * | 2008-12-23 | 2018-06-19 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | "processos para preparar um inibidor de protease de hcv macrocíclico e intermediários e uso". |
| EP3150596A1 (en) * | 2009-02-27 | 2017-04-05 | Janssen Pharmaceuticals, Inc. | Amorphous salt of a macrocyclic inhibitor of hcv |
| US8377962B2 (en) | 2009-04-08 | 2013-02-19 | Idenix Pharmaceuticals, Inc. | Macrocyclic serine protease inhibitors |
| US9284307B2 (en) | 2009-08-05 | 2016-03-15 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors |
| KR101781789B1 (ko) | 2010-01-27 | 2017-09-26 | 에이비 파르마 리미티드. | C형 간염 바이러스 억제제로 사용되는 다환 헤테로사이클릭 화합물 |
| US9586893B2 (en) * | 2010-03-16 | 2017-03-07 | Janssen Pharmaceuticals | Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV |
| US9353100B2 (en) | 2011-02-10 | 2016-05-31 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections |
| US8957203B2 (en) | 2011-05-05 | 2015-02-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8691757B2 (en) | 2011-06-15 | 2014-04-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8962810B2 (en) | 2011-06-16 | 2015-02-24 | AB Pharma Ltd. | Macrocyclic heterocyclic compound for inhibiting hepatitis C virus and preparation and use thereof |
| KR20140063726A (ko) * | 2011-09-22 | 2014-05-27 | 얀센 파마슈티칼즈, 인코포레이티드 | Hcv의 거대고리 단백질 분해효소 억제제의 제조 방법 및 중간물질 |
| PL2820009T3 (pl) | 2012-03-01 | 2018-09-28 | Array Biopharma, Inc. | Inhibitory kinaz serynowo/treoninowych |
| WO2013137330A1 (ja) * | 2012-03-14 | 2013-09-19 | 積水メディカル株式会社 | 光学活性２－ビニルシクロプロパン－１，１－ジカルボン酸エステルの製造法 |
| CN103387509B (zh) * | 2012-05-11 | 2016-06-08 | 重庆博腾制药科技股份有限公司 | 一种hcv蛋白酶抑制剂中间体的制备方法 |
| MX360452B (es) | 2012-10-19 | 2018-11-01 | Bristol Myers Squibb Co | Inhibidores del virus de la hepatitis c. |
| US9643999B2 (en) | 2012-11-02 | 2017-05-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP2914613B1 (en) | 2012-11-02 | 2017-11-22 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| EP2914598B1 (en) | 2012-11-02 | 2017-10-18 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| US9409943B2 (en) | 2012-11-05 | 2016-08-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| FR2998892B1 (fr) | 2012-12-04 | 2015-01-02 | Pf Medicament | Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments |
| JP6342922B2 (ja) | 2013-03-07 | 2018-06-13 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｃ型肝炎ウイルス阻害剤 |
| CN105175406B (zh) * | 2014-06-09 | 2019-06-04 | 深圳翰宇药业股份有限公司 | Hcv抑制剂的中间体以及由其制备hcv抑制剂的方法 |
| CN105237528B (zh) * | 2014-06-09 | 2019-06-04 | 深圳翰宇药业股份有限公司 | Hcv抑制剂的中间体以及由其制备hcv抑制剂的方法 |
| MA41812A (fr) | 2015-03-27 | 2018-01-30 | Janssen Pharmaceuticals Inc | Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc |
| CN107098805A (zh) * | 2017-05-17 | 2017-08-29 | 盐城同泰化工科技有限公司 | 一种4‑环戊酮‑1，2‑二甲酸的制备方法 |
| CN115850070B (zh) * | 2022-12-13 | 2025-11-21 | 渭南高新区海泰新型电子材料有限责任公司 | 一种环己烷二羧酸单酯类化合物的合成方法 |
| CN118652174B (zh) * | 2024-08-21 | 2025-03-14 | 兰州大学 | 一种酸性树脂催化ε-己内酯接枝丙烯酸羟乙酯类化合物的方法 |
| CN118652175A (zh) * | 2024-08-21 | 2024-09-17 | 兰州大学 | 一种磷酸芳香酯催化ε-己内酯接枝丙烯酸羟乙酯类化合物的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA74546C2 (en) | 1999-04-06 | 2006-01-16 | Boehringer Ingelheim Ca Ltd | Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition |
| US7125845B2 (en) | 2003-07-03 | 2006-10-24 | Enanta Pharmaceuticals, Inc. | Aza-peptide macrocyclic hepatitis C serine protease inhibitors |
| SI1713823T1 (sl) | 2004-01-30 | 2010-04-30 | Medivir Ab | Inhibitorji HCV NS-3 serin proteaze |
| PE20070211A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| PE20070343A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Inhibidores macrociclicos del virus de la hepatitis c |
| HRP20100429T1 (hr) * | 2007-02-01 | 2010-09-30 | Tibotec Pharmaceuticals | Postupci i intermedijeri za pripravu makrocikličkog inhibitora proteaze za hcv |
-
2008
- 2008-02-01 HR HR20100429T patent/HRP20100429T1/hr unknown
- 2008-02-01 AT AT08708576T patent/ATE467630T1/de active
- 2008-02-01 CN CN200880003655.7A patent/CN101600713B/zh not_active Expired - Fee Related
- 2008-02-01 MX MX2009008271A patent/MX2009008271A/es active IP Right Grant
- 2008-02-01 CN CN201510477307.5A patent/CN105111200A/zh active Pending
- 2008-02-01 TW TW097103908A patent/TWI455936B/zh not_active IP Right Cessation
- 2008-02-01 ES ES08708576T patent/ES2345857T3/es active Active
- 2008-02-01 DK DK08708576.7T patent/DK2121674T3/da active
- 2008-02-01 BR BRPI0806853-4A patent/BRPI0806853B1/pt not_active IP Right Cessation
- 2008-02-01 PT PT08708576T patent/PT2121674E/pt unknown
- 2008-02-01 RU RU2009132673/04A patent/RU2483067C2/ru not_active IP Right Cessation
- 2008-02-01 WO PCT/EP2008/051269 patent/WO2008092955A1/en not_active Ceased
- 2008-02-01 DE DE602008001251T patent/DE602008001251D1/de active Active
- 2008-02-01 EP EP08708576A patent/EP2121674B1/en active Active
- 2008-02-01 SI SI200830052T patent/SI2121674T1/sl unknown
- 2008-02-01 US US12/441,927 patent/US8212043B2/en not_active Expired - Fee Related
- 2008-02-01 AR ARP080100428A patent/AR065137A1/es unknown
- 2008-02-01 AU AU2008209697A patent/AU2008209697B2/en not_active Ceased
- 2008-02-01 KR KR1020097015349A patent/KR101598135B1/ko not_active Expired - Fee Related
- 2008-02-01 PL PL08708576T patent/PL2121674T3/pl unknown
- 2008-02-01 CA CA2677173A patent/CA2677173C/en not_active Expired - Fee Related
- 2008-02-01 CN CN201310036125.5A patent/CN103145699B/zh not_active Expired - Fee Related
- 2008-02-01 JP JP2009547703A patent/JP5563830B2/ja not_active Expired - Fee Related
- 2008-02-01 CL CL200800322A patent/CL2008000322A1/es unknown
-
2009
- 2009-06-10 IL IL199276A patent/IL199276A/en active IP Right Grant
-
2010
- 2010-08-09 CY CY20101100740T patent/CY1110893T1/el unknown
-
2012
- 2012-05-31 US US13/484,881 patent/US8722892B2/en not_active Expired - Fee Related
-
2016
- 2016-05-26 HK HK16106009.8A patent/HK1217952A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2008000322A1 (es) | Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios. | |
| CL2008000355A1 (es) | Procedimiento de preparacion de un compuesto derivado de 1-metil-2-fenilamino metil-1h-benzoimidazol-5-amida; compuesto intermediario hidrobromuro. | |
| CL2007001040A1 (es) | Proceso para la preparacion de antagonista de la sustancia p derivado de acil-amino-alquilen-amida. | |
| DK2431359T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
| DK2021486T4 (da) | System til fremstilling af bioorganiske forbindelser | |
| BRPI0911254A2 (pt) | processo para a preparação de um composto | |
| BRPI0818533A2 (pt) | composto, composição farmacêutica, e, processo para a preparação de um composto | |
| IL198186A (en) | Mphosph1 derived peptide vaccines | |
| ES2380489T8 (es) | Proceso para la síntesis de compuestos orgánicos | |
| NO20076030L (no) | Fremgangsmåte for fremstilling av hydroklorsilaner | |
| BRPI0911897A2 (pt) | Processo para a preparação de compostos, e, composto | |
| ITBO20060719A1 (it) | Macchina per la produzione di filtri composti. | |
| CL2007003875A1 (es) | Compuestos derivados de amidas del acido 3-amino tetrahidrofurano-3-carboxilico; procedimiento de preparacion de dichos compuestos. | |
| CL2014002318A1 (es) | Procedimiento para la separación de ésteres de alquilo (divisional de solicitud n° 1387-2010) | |
| BRPI0817010A2 (pt) | Processo de preparação de um composto p-hidroximandélico eventualmente substituído e derivado e de um aldeído 4-hidroxiaromático. | |
| BRPI0921210A2 (pt) | processos para a preparação de compostos de arilaminas | |
| ITBO20060720A1 (it) | Macchina per la produzione di filtri composti. | |
| BRPI0818422A2 (pt) | Processo para a preparação de melamina. | |
| BRPI0912512A2 (pt) | Processo para a preparação de compostos | |
| BRPI0907052A2 (pt) | Processo para a preparação de compostos | |
| IL185335A0 (en) | Process for the preparation of substituted benzoxazole compounds | |
| FI20085807A0 (fi) | Menetelmä essitalopraamin valmistamiseksi | |
| ITBO20060718A1 (it) | Macchina per la produzione di filtri composti |